[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Sanchez et al., 2021 - Google Patents

Novel eye drop delivery aid improves outcomes and satisfaction

Sanchez et al., 2021

View HTML
Document ID
6082182314136176332
Author
Sanchez F
Mansberger S
Kung Y
Gardiner S
Burgoyne C
Cunningham Jr E
Rees J
Jones E
Kinast R
Publication year
Publication venue
Ophthalmology Glaucoma

External Links

Snippet

Purpose To compare a nose-pivoted drop delivery device (NPDD) with traditional eye drop delivery in glaucoma subjects. Design Repeated-measures case series. Participants Fifty glaucoma subjects (100 eyes) who reported difficulty self-administering eye drops. Methods …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0016—Operational features thereof
    • A61B3/0033—Operational features thereof characterised by user input arrangements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications

Similar Documents

Publication Publication Date Title
Hennessy et al. A video study of drop instillation in both glaucoma and retina patients with visual impairment
Solomon et al. Intravitreal bevacizumab versus ranibizumab for treatment of neovascular age-related macular degeneration: findings from a cochrane systematic review
Wroblewski et al. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion
Hennessy et al. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss
Sanchez et al. Novel eye drop delivery aid improves outcomes and satisfaction
Narayanaswamy et al. Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial
Ohba et al. The 100 most frequently cited articles in ophthalmology journals
TW201249459A (en) Method of treating vision disorders
Lazcano-Gomez et al. Videographic assessment of glaucoma drop instillation
Lee et al. Acupuncture for dry eye syndrome after refractive surgery: A randomized controlled pilot trial
Craig et al. TFOS lifestyle report executive summary: A lifestyle epidemic–Ocular surface disease
Pucker et al. Evaluation of systane complete for the treatment of contact lens discomfort
Naito et al. Factors affecting eye drop instillation in glaucoma patients with visual field defect
Schlenker et al. Standalone ab interno gelatin stent versus trabeculectomy: postoperative interventions, visual outcomes, and visits
Kang et al. Health literacy and success with glaucoma drop administration
Wirta et al. A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)
Naito et al. Comparison of success rates in eye drop instillation between sitting position and supine position
Koval et al. Intracameral triamcinolone acetonide in glaucoma surgery: a prospective randomized controlled trial
Jackson et al. The effect of off-the-visual-axis retinoscopy on objective refractive measurement
Sheppard et al. Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?
Maberley et al. Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial
Eriş Association between choroidal vascular density, age and sex: A prospective study
Ritch et al. An improved technique of eye drop self-administration for patients with limited vision
Katz et al. Bilateral Effect of OC-01 (Varenicline Solution) nasal spray for treatment of signs and symptoms in individuals with mild, moderate, and severe dry eye disease
Hashem et al. Ten-year outcomes of LASIK for pediatric myopic anisometropia